Variables | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95%CI) | p | HR (95%CI) | p | |
PFS | ||||
Gender (female vs. male) | 0.816 (0.401–1.658) | 0.574 | - | - |
Age (> 55 vs. ≤ 55) | 1.619 (0.780–3.362) | 0.196 | - | - |
Smoke (yes vs. no) | 1.121 (0.568–2.214) | 0.741 | - | - |
AJCC stage (8th) (III-IVb vs. I-II) | 1.602 (0.730–3.516) | 0.240 | - | - |
Tumor classification (T3-4 vs. T1-2) | 1.873 (0.921–3.809) | 0.083 | - | - |
Node classification (N2-3 vs. N0-1) | 1.021 (0.530–1.965) | 0.951 | - | - |
Metastasis (Yes vs. No) | 1.894 (0.454–7.893) | 0.381 | - | - |
WHO pathologic type (TypeIIb vs. TypeIIa vs. TypeI) | 1.154 (0.354–3.762) | 0.813 | - | - |
Leukocytes (> 9.5 vs. ≤ 9.5) | 1.835 (0.649–5.189) | 0.253 | - | - |
Neutrophils (> 6.3 vs. ≤ 6.3) | 2.133 (0.829–5.489) | 0.116 | - | - |
Lymphocytes (> 3.2 vs. ≤ 3.2) | 1.952 (0.468–8.145) | 0.359 | - | - |
Monocytes (> 0.6 vs. ≤ 0.6) | 1.355 (0.526–3.491) | 0.529 | - | - |
Platelets (> 300 vs. ≤ 300) | 3.248 (1.622–6.504) | 0.001 | 1.976 (0.897–4.354) | 0.091 |
SII (> 655.54 vs. ≤ 655.54) | 3.876 (2.005–7.493) | < 0.001 | 1.467 (0.558–3.861) | 0.437 |
SIRI (> 1.12 vs. ≤ 1.12) | 4.471 (2.303–8.678) | < 0.001 | 3.032 (1.251–7.348) | 0.014 |
OS | ||||
Gender (female vs. male) | 0.727 (0.259–2.038) | 0.544 | - | - |
Age (> 55 vs. ≤ 55) | 2.734 (1.058–7.065) | 0.038 | 2.412 (0.928–6.271) | 0.071 |
Smoke (yes vs. no) | 2.010 (0.798–5.064) | 0.139 | - | - |
AJCC stage (8th) (III-IVb vs. I-II) | 3.763 (0.865–16.371) | 0.077 | - | - |
Tumor classification (T3-4 vs. T1-2) | 2.972 (0.978–9.035) | 0.055 | - | - |
Node classification (N2-3 vs. N0-1) | 1.135 (0.450–2.859) | 0.789 | - | - |
Metastasis (Yes vs. No) | 3.916 (0.899–17.064) | 0.069 | - | - |
WHO pathologic type (TypeIIb vs. TypeIIa vs. TypeI) | 1.814 (0.241–13.636) | 0.563 | - | - |
Leukocytes (> 9.5 vs. ≤ 9.5) | Not estimable | - | Not estimable | - |
Neutrophils (> 6.3 vs. ≤ 6.3) | Not estimable | - | Not estimable | - |
Lymphocytes (> 3.2 vs. ≤ 3.2) | Not estimable | - | Not estimable | - |
Monocytes (> 0.6 vs. ≤ 0.6) | 0.525 (0.070–3.949) | 0.531 | - | - |
Platelets (> 300 vs. ≤ 300) | 2.282 (0.813–6.410) | 0.117 | - | - |
SII (> 655.54 vs. ≤ 655.54) | 3.563 (1.404–9.039) | 0.007 | 1.416 (0.434–4.626) | 0.564 |
SIRI (> 1.12 vs. ≤ 1.12) | 5.527 (2.129–14.348) | < 0.001 | 4.141 (1.230–13.935) | 0.022 |